1. Pharmacopoeia Committee, Ministry of Health, PRC, Drug Standard of Ministry of Public Health of the Peoples Republic of China, traditional Chinese medicine preparation, 14 volumes, China, 1997.
2. Central People's Government of the People's Republic of China, Catalogue of National Basic Drugs (2018 Edition) and interpretation. 〈http://www.gov.cn/fuwu/2018–10/30/5335721/files/e7473e46d9b24aadad3eb25127ffd986.pdf〉, 2018 (accessed 30 September 2018).
3. Central People's Government of the People's Republic of China, Notice of the Ministry of Human Resources and Social Security of the National Medical Insurance Administration on printing and distributing the Catalogue of Medicines for National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance (2021). 〈http://www.gov.cn/zhengce/zhengceku/2021–12/03/5655651/files/c8fa387d8a134bfb83c2a838dc447b82.pdf〉, 2021 (accessed 24 November 2021).
4. Objective: to analyze the effect of Huachansu tablets on coagulation status, therapeutic effect and quality of life of patients with advanced lung cancer, Guide of China;Lv;Medicine,2019
5. Observation on the curative effect of cinobufotalin tablets in the standardized treatment of cancer pain;Yu;Modern J. Integr. Tradit. Chin. West. Med.,2015